We have shown previously that berberine, an alkaloid isolated from Chinese herbs, interferes with cancer cell metabolism through many different pathways and targets, including but not limited to glycolysis (PKM2, PFKP) and fatty acid synthesis (ACC, ACL) [31, 93, 94]. The gene discussed is PFKP; the disease is cancer.